Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-11 | Amended | $58,510,656 | Unknown | Equity Only | SEC link | |
| 2025-04-30 | Amended | $53,441,210 | $2,500,000 | Equity Only | 06b | SEC link |
| 2024-04-23 | New | $50,941,210 | $50,941,210 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Steve Altschuler | Director, Executive |
| Andrew Bellinger | Director |
| Andrew Cornforth | Executive |
| Alan Ezekowitz | Director |
| Nichols Garrett | Executive |
| Jonathan Kagan | Director, Executive |
| Jeffrey Karp | Executive |
| Richard Malley | Director |
| Nick Seaver | Director, Executive |